Inhibition of Tumor Growth and Angiogenesis by a Dextran Derivative
Author Information
Author(s): R Bagheri-Yarmand, Y Kourbalil, C Mabilat, JF Morere, A Martin, H Lu, C Soria, J Jozefonvicze, M Crepin
Primary Institution: Laboratoire d'Oncologie Moleculaire Humaine, Université de Paris-Nord
Hypothesis
CMDB7 inhibits FGF-2/FGF-4-dependent tumor growth and angiogenesis.
Conclusion
CMDB7 is an effective inhibitor of tumor growth and angiogenesis in vivo.
Supporting Evidence
- CMDB7 treatment suppressed tumor take and growth by about 50% and 80%, respectively.
- Immunohistochemical analysis showed a significant decrease in endothelial density in treated tumors.
- CMDB7 inhibited the mitogenic activities of conditioned media from breast cancer cell lines.
Takeaway
A special substance called CMDB7 helps stop tumors from growing by blocking the blood supply they need.
Methodology
The study involved in vitro assays on cell lines and in vivo experiments using nude mice to assess the effects of CMDB7 on tumor growth and angiogenesis.
Limitations
The study primarily focused on specific cell lines and may not fully represent all breast cancer types.
Participant Demographics
Swiss nude male athymic mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.00001
Confidence Interval
95%
Statistical Significance
p<0.00001
Want to read the original?
Access the complete publication on the publisher's website